Institutional Ownership
Newamsterdam Pharma Company
CUSIP N62509117*W EXP 99/99/999Q1 2026
Institutional Holders
9
13F filers
Shares Held
1.30M
Aggregate institutional
Institutional Value
$25.87M
Q1 2026
Net New Holders
+1
1 new · 0 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions1
Increased0
Decreased1
Sold out0
Institutional Holders
9 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 500.3K | $10.03M | 0 | Held |
| 2 | Ra Capital Management, L.P. | 333.3K | $6.68M | 0 | Held |
| 3 | Affinity Asset Advisors, LLC | 245.0K | $4.91M | 0 | Held |
| 4 | Bain Capital Life Sciences Investors, LLC | 100.0K | $2.00M | 0 | Held |
| 5 | Deerfield Management Company, L.P. | 92.8K | $1.86M | 0 | Held |
| 6 | Aristeia Capital, L.L.C. | 15.7K | $342.7K | 0 | Held |
| 7 | Wolverine Asset Management LLC | 2.1K | $42.6K | +2.1K | New |
| 8 | Ubs Group AG | 396 | $7.9K | 0 | Held |
| 9 | Vestcor Inc | 6.7K | $131 | −3.0K | Reduced |